Flores Osvaldo 4
4 · Century Therapeutics, Inc. · Filed Feb 6, 2023
Insider Transaction Report
Form 4
Flores Osvaldo
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-02+637,500→ 637,500 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (637,500 underlying) - Award
Stock Option (right to buy)
2023-02-02+637,500→ 637,500 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (637,500 underlying)
Footnotes (1)
- [F1]The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.